difficulty in transfecting siRNAs in vivo. Recently, chemically modulated siRNAs which do not require transfection agents or other additional techniques such as electroporation in transfecting into cells have been developed. These siRNAs can be applied simply to cells with low cellular toxicity, and is likely to be suitable for in vivo use. Previous studies have demonstrated that the effects of intra-articular injection of ADAMTS5 or MMP13 siRNA into the knee on the delay and attenuation of articular cartilage degeneration. However, the effect of the combined siRNA injection of these two proteases is not clear. Therefore, purpose of this sturdy is to examine the effect of administration of chemically modulated MMP13 siRNA alone or in combination with ADAMTS5 siRNA in a mice OA model. Methods: OA pathology was surgically induced to C57BL/6 mice by destabilization of the medial meniscus (DMM) method, by transecting the medial meniscotibial ligament under general anesthesia. Three different siRNA injections against the DMM model were evaluated. MMP13 siRNA group was injected chemically modulated MMP13 siRNA one week after DMM surgery. Combined siRNA group was injected ADAMTS5 siRNA three days after the surgery and MMP13 siRNA four days later. Control siRNA group was injected non targeting siRNA which does not target to any gene. Histological assessment of articular cartilage at 8 weeks post DMM surgery was conducted to assess the effect of siRNA injections in osteoarthritis progression, according to the OARSI recommendation for OA knee scoring in mice. Results: Fibrillation and loss of Safranin O staining of the cartilage surface were observed in control siRNA group. Improvement was observed in the histological score in both treated group compared to the control siRNA injected group. Especially in combined siRNA group, the score was lower than MMP13 siRNA group. Conclusions: Combined treatment with MMP13 siRNA and ADAMTS5 siRNA intra-articular injection can be expected to inhibit cartilage degradation at the early phase of OA development compared to treatment MMP13 siRNA alone.
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COLLAGEN TYPE III DEPOSITION IN ARTICULAR CARTILAGE MAY BE A DISTINCTIVE BIOMARKER OF HIP OSTEOARTHRITIS
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Objective: To determine if collagen type III deposition in osteoarthritic articular cartilage is a significant contributor to the pool of collagen. Method and material: Site matched cartilage of 10 femoral heads from OA and fracture patients (reference cartilage) were examined. Femoral heads were obtained from surgery of total hip replacement due to OA and femoral neck fracture. Cartilage was pulverized and treated by achymotrypsin, an enzyme which selectively extracts damaged collagen. The amount of collagen in both the extract and the remaining residue has been analyzed by hydroxyproline assay. Another pulverized cartilage specimen was used for a proteomics approach which includes tissue extraction by guanidine hydrochloride (4M GuHCl), digestion and reversed phase separations coupled to tandem mass spectrometry for the identification and quantification of peptides. The peak areas of targeted collagen peptides were measured and compared between OA and fracture patients.
Results: Amount of extracted pool of collagen in chymotrypsin extracted OA cartilage was 3 folds higher than reference cartilage. The amount of total collagen (based on hydroxyproline) in both groups did not differ statistically. The proteomics results showed more newly synthesized type III collagen in OA cartilage compared with references.
The proteomics results showed that newly synthesized type III collagen occurred almost exclusively in OA cartilage compared with references. Conclusion: This study implies the addition of collagen type III as shown by the fraction of newly synthesized pool of collagen III to the collagenous matrix of OA cartilage in adult human joints, suggesting an active remodeling process. The greater extractable pool in OA than control cartilage may offer a potential biomarker for OA. Whether increased collagen type III extractability reflects pathological activity, an active repair mechanism or both remains to be established. Results: The split line patterns of patella, femur, and tibia were found to be consistent over seven knee joints harvested from New Zealand white rabbits allowing us to proceed to the next step of introducing cracks. Preliminary results show around 10% deeper indentations in cartilage cracked perpendicular to the split lines vs. intact cartilage with around 20% reduction in time to reach a steady-state plateau after stress relaxation ( Figure 3 ). Histological analysis revealed that chondrocytes clusters in the radial zone show compression in the vertical direction and realignment of their long axis from the natural vertical orientation to an oblique pattern pointing away from the center of compression site. On Linear Polarized Microscopy (LPM), extensive collagen fiber reorientation is apparent (Figure 4 ), giving the impression that collagen fibers organize in two populations: 1-big pillars that can be seen in uncompressed and compressed intact (non-cracked) cartilage, and 2-small and free movable bundle groups that become more apparent under compression and reorient at 45 to the surface of the cartilage. Data collection is still in progress. We expect that stress-relaxation will be faster when the split lines are perpendicular to the crack and when cracks are made at smaller angles relative to the surface of the cartilage. Deformations of cracked edges and the extent of area affected by the loading will be identified too. Conclusions: Even it is still early to draw conclusions from our preliminary results, it appears that the presence of a crack increases the amplitude of deformation applied to chondrocytes while lowering the time of high interstitial fluid pressure applied to chondrocytes by a given load, which may be significant to chondrocytes metabolism. The organization of collagen fibers may indicate that the big pillar fiber bundles limit the overall deformation of cartilage while the small bundles reduce the amount of deformation transmitted to chondrocytes. Structural changes in surface zone cartilage are among the earliest signs of very early OA. Understanding these changes in mechanics and cell signaling may allow altering the time course of OA by either mechanical intervention to normalize cell deformation and signaling in early OA, or pharmacological intervention to neutralize catabolic enzymes known to be released in chondrocytes near tissue cracks. Purpose: There is evidence for a vascular contribution to the pathogenesis of osteoarthritis. Our aim was to use an asymptomatic cohort to examine the association between popliteal artery wall thickness, previously shown to be associated with risk of generalized osteoarthritis, and knee structural changes. Methods: 297 adults with no significant knee pain, injury, or history of clinical knee disease were recruited. Participants underwent knee magnetic resonance imaging at baseline and 2 years later. Popliteal artery wall thickness, knee cartilage volume and bone marrow lesions (BML) were assessed. Results: Of 278 participants with valid popliteal artery wall thickness measurement, 254 (91.4%) completed 2-year follow-up. After adjusting for age, gender, body mass index and tibial bone area, increased popliteal artery wall thickness was associated with reduced medial tibial cartilage volume (B ¼ À6.7, 95% CI À12.9, À0.6, p ¼ 0.03) and increased rate of medial tibial cartilage volume loss (B ¼ 0.06, 95% CI 0.01, 0.12, p ¼ 0.03). There was a trend for medial tibiofemoral BML deterioration in relation to increased popliteal artery wall thickness (odds ratio¼1.07, 95% CI 0.99, 1.15, p ¼ 0.07). No significant associations were observed with lateral tibiofemoral compartment. Conclusion: Increased popliteal artery wall thickness was associated with adverse changes in knee structure, as evidenced by reduced medial tibial cartilage volume, increased rate of cartilage volume loss and a trend for BML deterioration over 2 years. These findings suggest an association between vascular pathology and early knee structural changes, supporting the hypothesis that vascular health may play a role in the development of knee osteoarthritis. Purpose: There is evidence for an association between levels of urinary C-telopeptide fragments of type II collagen (uCTX-II) and risk of knee osteoarthritis. The aim of this study was to examine the association between uCTX-II levels and knee cartilage and bone changes in middleaged women without clinical knee disease. Methods: 140 women, aged 40 -67 years, with no significant knee pain, knee injury or any forms of arthritis, underwent knee MRI at baseline and two years later. Cartilage volume, cartilage defects, tibial plateau bone area and bone marrow lesions (BMLs) were measured using validated methods. Baseline uCTX-II was measured using ELISA. Results: A higher baseline uCTX-II level was associated with increased prevalence of medial tibiofemoral cartilage defects (OR 4.36, 95%CI 1.58-12.04), greater medial (regression coefficient 80.2, 95%CI 9.3-151.1) and lateral (regression coefficient 86.0, 95%CI 33.3-138.7) tibial plateau bone area, and increased prevalence of lateral tibiofemoral BMLs (OR 10.62, ). Baseline uCTX-II levels were not significantly associated with baseline tibial cartilage volume or changes in knee cartilage (volume and defects) or bone (bone area and BMLs) over two years.
ASSOCIATIONS BETWEEN LEVELS OF URINARY C-TELOPEPTIDE
Conclusion:
In middle-aged women without clinical knee disease, higher uCTX-II levels were associated with detrimental changes in knee cartilage and bone cross-sectionally but not over two years. This suggests that uCTX-II may be a sensitive biomarker of early structural features of knee osteoarthritis. Further work will be needed to determine its sensitivity to change and whether it predicts progression of disease over longer time periods.
